Evidence map›Paper›PMID 35551305›Full record

ArticleNature genetics2022

DeepSTARR predicts enhancer activity from DNA sequence and enables the de novo design of synthetic enhancers.

Bernardo P de Almeida, Franziska Reiter, Michaela Pagani, Alexander Stark

Abstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 185 papers.

0numbers the graph read from it
0cells of the map it votes in
185citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

185 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Emergence Biases in Molecular Evolution.Genome biology and evolution · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Genome evolution through polyploidy: Enhancing plant stress resilience in agriculture.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Review
  18. Article
  19. Article
  20. Article

125 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Bernardo P de AlmeidaResearch Institute of Molecular Pathology, Vienna BioCenter, Campus-Vienna-BioCenter 1, Vienna, Austria.ORCID http://orcid.org/0000-0002-6084-6775
Franziska ReiterResearch Institute of Molecular Pathology, Vienna BioCenter, Campus-Vienna-BioCenter 1, Vienna, Austria.
Michaela PaganiResearch Institute of Molecular Pathology, Vienna BioCenter, Campus-Vienna-BioCenter 1, Vienna, Austria.
Alexander StarkResearch Institute of Molecular Pathology, Vienna BioCenter, Campus-Vienna-BioCenter 1, Vienna, Austria. stark@starklab.org.ORCID http://orcid.org/0000-0003-2611-0841

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enhancer sequences control gene expression and comprise binding sites (motifs) for different transcription factors (TFs). Despite extensive genetic and computational studies, the relationship between DNA sequence and regulatory activity is poorly understood, and de novo enhancer design has been challenging. Here, we built a deep-learning model, DeepSTARR, to quantitatively predict the activities of thousands of developmental and housekeeping enhancers directly from DNA sequence in Drosophila melanogaster S2 cells. The model learned relevant TF motifs and higher-order syntax rules, including functionally nonequivalent instances of the same TF motif that are determined by motif-flanking sequence and intermotif distances. We validated these rules experimentally and demonstrated that they can be generalized to humans by testing more than 40,000 wildtype and mutant Drosophila and human enhancers. Finally, we designed and functionally validated synthetic enhancers with desired activities de novo.

Indexed as

Drosophila melanogasterEnhancer Elements, GeneticAnimalsBase SequenceBinding SitesDrosophilaGene Expression Regulation, DevelopmentalTranscription FactorsTranscription Factors

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.